Search Results
Mar 29, 2026, 08:46 ET BSX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026
contact the firm, including whistleblowers, former employees, shareholders and others.To learn more about the Boston Scientific class action, go to
More news about: Faruqi & Faruqi, LLP
Mar 29, 2026, 08:43 ET AQST DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics Investors of Securities Class Action Deadline on May 4, 2026
to contact the firm, including whistleblowers, former employees, shareholders and others.To learn more about the Aquestive class action, go to
More news about: Faruqi & Faruqi, LLP
Mar 29, 2026, 08:41 ET GEMI DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Gemini Space Station (GEMI) Investors of Securities Class Action Deadline on May 18, 2026
the firm, including whistleblowers, former employees, shareholders and others.To learn more about the Gemini Space Station class action, go to
More news about: Faruqi & Faruqi, LLP
Mar 29, 2026, 08:38 ET LU DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Lufax (LU) Investors of Securities Class Action Deadline on May 20, 2026
conduct to contact the firm, including whistleblowers, former employees, shareholders and others.To learn more about the Lufax class action, go to
More news about: Faruqi & Faruqi, LLP
Mar 29, 2026, 08:35 ET NKTR DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026
the firm, including whistleblowers, former employees, shareholders and others.To learn more about the Nektar Therapeutics class action, go to
More news about: Faruqi & Faruqi, LLP
Mar 29, 2026, 08:33 ET MNDY DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds monday.com (MNDY) Investors of Securities Class Action Deadline on May 11, 2026
contact the firm, including whistleblowers, former employees, shareholders and others.To learn more about the monday.com class action, go to
More news about: Faruqi & Faruqi, LLP
Mar 29, 2026, 08:27 ET SMR DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds NuScale (SMR) Investors of Securities Class Action Deadline on April 20, 2026
firm, including whistleblowers, former employees, shareholders and others.To learn more about the NuScale Power Corporation class action, go to
More news about: Faruqi & Faruqi, LLP
Mar 29, 2026, 08:25 ET IBRX SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026
contact the firm, including whistleblowers, former employees, shareholders and others.To learn more about the ImmunityBio class action, go to
More news about: Faruqi & Faruqi, LLP
Mar 29, 2026, 08:22 ET PYPL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds PayPal Investors of Securities Class Action Deadline on April 20, 2026
conduct to contact the firm, including whistleblowers, former employees, shareholders and others.To learn more about the PayPal class action, go to
More news about: Faruqi & Faruqi, LLP
Mar 29, 2026, 08:19 ET QURE DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026
to contact the firm, including whistleblowers, former employees, shareholders and others.To learn more about the uniQure class action, go to
More news about: Faruqi & Faruqi, LLP
Mar 29, 2026, 08:18 ET PSFE DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Paysafe (PSFE) Investors of Securities Class Action Deadline on April 7, 2026
contact the firm, including whistleblowers, former employees, shareholders and others.To learn more about the Paysafe Limited class action, go to
More news about: Faruqi & Faruqi, LLP
Mar 29, 2026, 08:14 ET RARE DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Ultragenyx Investors of Securities Class Action Deadline on April 6, 2026
firm, including whistleblowers, former employees, shareholders and others.To learn more about the Ultragenyx Pharmaceutical class action, go to
More news about: Faruqi & Faruqi, LLP
Mar 29, 2026, 08:13 ET PMI DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Picard Medical (PMI) Investors of Securities Class Action Deadline on April 13, 2026
contact the firm, including whistleblowers, former employees, shareholders and others.To learn more about the Picard Medical class action, go to
More news about: Faruqi & Faruqi, LLP
Mar 29, 2026, 08:11 ET TCOM DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Trip.com Group (TCOM) Investors of Securities Class Action Deadline on May 11, 2026
to contact the firm, including whistleblowers, former employees, shareholders and others.To learn more about the Trip.com class action, go to
More news about: Faruqi & Faruqi, LLP
Mar 29, 2026, 08:08 ET RR DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Richtech Robotics Investors of the Securities Class Action Lawsuit Deadline on April 3, 2026
contact the firm, including whistleblowers, former employees, shareholders and others.To learn more about the Richtech Robotics class action, go to
More news about: Faruqi & Faruqi, LLP
Mar 29, 2026, 08:07 ET RGNX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds REGENXBIO Investors of Securities Class Action Deadline on April 14, 2026
to contact the firm, including whistleblowers, former employees, shareholders and others.To learn more about the REGENXBIO class action, go to
More news about: Faruqi & Faruqi, LLP
Mar 29, 2026, 08:05 ET METC DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Ramaco Investors of Securities Class Action Deadline on March 31, 2026
contact the firm, including whistleblowers, former employees, shareholders and others.To learn more about the Ramaco Resources class action, go to
More news about: Faruqi & Faruqi, LLP
Mar 29, 2026, 08:01 ET POM DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Pomdoctor Investors of Securities Class Action Deadline on April 13, 2026
to contact the firm, including whistleblowers, former employees, shareholders and others.To learn more about the Pomdoctor class action, go to
More news about: Faruqi & Faruqi, LLP
Mar 29, 2026, 04:51 ET ENPH DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Enphase Energy Investors of Securities Class Action Deadline on April 20, 2026
the firm, including whistleblowers, former employees, shareholders and others.To learn more about the Enphase Energy, Inc. class action, go to
More news about: Faruqi & Faruqi, LLP
Mar 28, 2026, 19:47 ET HTGC Investors Have Opportunity to Lead Hercules Capital, Inc. Securities Fraud Lawsuit
without payment of any out of pocket fees or costs through a contingency fee arrangement.What to do next: To join the Hercules Capital class action, go to
More news about: THE ROSEN LAW FIRM, P. A.
Mar 28, 2026, 19:30 ET PSIX Investors Have Opportunity to Lead Power Solutions International, Inc. Securities Fraud Lawsuit
without payment of any out of pocket fees or costs through a contingency fee arrangement.What to do next: To join the Power Solutions class action, go to
More news about: THE ROSEN LAW FIRM, P. A.
Mar 28, 2026, 18:35 ET LU Investors Have Opportunity to Lead Lufax Holding Ltd Securities Fraud Lawsuit First Filed by the Firm
compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.What to do next: To join the Lufax class action, go to
More news about: THE ROSEN LAW FIRM, P. A.
Mar 28, 2026, 18:04 ET FBRT Investors Have Opportunity to Lead Franklin BSP Realty Trust, Inc. Securities Fraud Lawsuit First Filed by the Rosen Law Firm
payment of any out of pocket fees or costs through a contingency fee arrangement.What to do next: To join the Franklin BSP Realty class action, go to
More news about: THE ROSEN LAW FIRM, P. A.
Mar 28, 2026, 15:31 ET ALIT Investors Have Opportunity to Lead Alight, Inc. Securities Fraud Lawsuit
compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.What to do next: To join the Alight class action, go to
More news about: THE ROSEN LAW FIRM, P. A.
Mar 28, 2026, 15:15 ET Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity
1-800-222-1222 or go to the nearest hospital emergency room right away. Zepbound is approved as a 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg injection. Learn more Zepbound is a prescription medicine. For more information, call 1-800-LillyRx (1-800-545-5979) [or go to
More news about: Eli Lilly and Company